|
C8ORF37 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1696977547947E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.30640054329945E-10 |
| Normal-vs-Stage2 |
4.74160000041302E-07 |
| Normal-vs-Stage3 |
2.35977903884077E-12 |
| Normal-vs-Stage4 |
2.94986257642904E-13 |
| Stage1-vs-Stage2 |
2.007000E-01 |
| Stage1-vs-Stage3 |
2.464100E-02 |
| Stage1-vs-Stage4 |
6.257300E-03 |
| Stage2-vs-Stage3 |
4.919000E-03 |
| Stage2-vs-Stage4 |
2.139000E-03 |
| Stage3-vs-Stage4 |
6.518600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.8680174314959E-12 |
| Normal-vs-AfricanAmerican |
1.574390E-04 |
| Normal-vs-Asian |
8.38259461843904E-11 |
| Caucasian-vs-AfricanAmerican |
1.111180E-01 |
| Caucasian-vs-Asian |
9.152200E-01 |
| AfricanAmerican-vs-Asian |
1.758410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.99345009785657E-12 |
| Normal-vs-Female |
6.03129768350641E-11 |
| Male-vs-Female |
1.143970E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.17570464054052E-11 |
| Normal-vs-Age(41-60Yrs) |
2.89539503484093E-11 |
| Normal-vs-Age(61-80Yrs) |
6.32940366784851E-11 |
| Normal-vs-Age(81-100Yrs) |
1.614340E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.329000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.567000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.794000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.849000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.139800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.906400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.46800000000592E-05 |
| Classical-VS-Follicular |
6.762300E-02 |
| Classical-VS-Other |
7.943000E-01 |
| Classical-VS-Normal |
1.25820021068535E-10 |
| Tall-VS-Follicular |
1.59163999999823E-05 |
| Tall-VS-Other |
4.018600E-01 |
| Tall-VS-Normal |
1.64368518795754E-12 |
| Follicular-VS-Other |
4.418800E-01 |
| Follicular-VS-Normal |
7.85560000382546E-08 |
| Other-VS-Normal |
3.618700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.89750470680883E-13 |
| Normal-vs-N1 |
8.78186412478499E-14 |
| N0-vs-N1 |
9.374900E-04 |
|
|
